$SBOT. Stellar Biotechnologies to Supply KLH to National Institutes of Health https://m.marketscreener.com/news/Stellar-Biotechnologies-to-Supply-KLH-to-National-Institutes-of-Health--27257483/ "This contract opens a new potential growth opportunity for KLH outside the KLH-conjugate vaccines clinical studies that we are currently supporting." total Assets almost been doubled $12.8m while total liabilities only 400k, net assets is $12.4m vs $7m Market cap. financed recently.